This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 10

Based on the information you provided, we found the following studies.

  • ABI-007-PANC-009 Open-label Ph 1/2 study of metronomic 5-fluorouracil in combination with nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin in subjects with metastatic pancreatic adenocarcinoma Study purpose: learn about the safety and potential benefit of metronomic 5-fluorouracil in combination with nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin in treating subjects with metastatic pancreatic adenocarcinoma.This combinations use in this study is investigational. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study of ponatinib for advanced cancers with genomic alterations in fibroblastic growth factor receptor (FGFR) and other genomic targets (KIT, PDGFRa, RET FLT3, ABL1) The purpose of this study is to find out what effects; good and/or bad, ponatinib has on you and your cancer. Your body has proteins that are involved in a cancer’s ability to grow and survive. The drug, Ponatinib, may prevent these proteins from causing cancer growth. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Ph 2 Double-Blind Randomized Study of Gemcitabine, Abraxane + Placebo vs Gemcitabine, Abraxane + 1 or 2 Truncated Courses of Demcizumab in Subjects with Metastatic Pancreatic Ductal Adenocarcinoma Study goal: compare the efficacy and safety of 1 or 2 truncated courses of new experimental drug, demcizumab, when given in combination with gemcitabine and Abraxane® to gemcitabine and Abraxane® (plus placebo).Administration of Gemcitabine and Abraxane® is standard treatment for pancreatic cancer. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of investigational drug INCB054329 (Study Drug) in Subjects With Advanced Malignancies (INCB 54329-101) Study purpose:determine dose that is safe and tolerable and select the doses that will be studied further;understand how INCB054329 enters and leaves the body over time;understand how INCB054329 acts on and in the body;observe any effects INCB054329 may have on the growth of certain types of cancers This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) Breast cancer CLL ( Chronic lymphocytic leukemia) Colon Cancer ( Malignant tumor of colon ) Lung cancer Pancreatic cancer Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I, open-label, dose escalation study of oral LGK974 in patients with malignancies dependent on Wnt ligands This research study is to find out if the study drug LGK974 is safe and has beneficial effects in people who have pancreatic adenocarcinoma, B-RAF mutant colorectal cancer, or tumors of other origin with specific genetic changes (also called mutations) upstream in the WNT signaling pathway. This study is researching all of the following topics: Colorectal / Colon / Rectal cancer Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Improving Adherence to Oral Cancer Agents and Self-Care of Symptoms Using an IVR The purpose of the study is to: (1) determine if daily reminders will help patients take their anti-cancer pills as prescribed and; (2) test strategies to manage symptoms between doctor office visits. We are hoping to learn better ways to support patients who are prescribed oral anti-cancer pills. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Melanoma Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • Phase 2 Study of Gemcitabine, Cisplatin +/- Veliparib in Patients With Pancreas Adenocarcinoma with BRCA/ PALB2 Mutation and a Phase 2 Study of Veliparib in Previously Treated Pancreas Adenocarcinoma Part 1: To evaluate a combination of gemcitabine and cisplatin with or without veliparib in subjects pancreatic cancer. Veliparib is a new drug that belongs to a class of drugs called PARP inhibitors. Part 2: To evaluate veliparib in subjects with previously treated advanced pancreatic cancer. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A research study treating patients who have a diagnosis of pancreatic cancer, that has been staged as borderline operable, with chemotherapy and radiation therapy prior to surgery. To examine the order and results of treatments including chemotherapy and radiation therapy and surgery for pancreatic tumors that are staged as borderline operable. This study is researching all of the following topics: Colon Cancer ( Malignant tumor of colon ) Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET) Goals:See if combination of temozolomide and pazopanib is safe and effective in improving outcomes.Part 1 will try to find out what effects this drug combination has on you and your cancer, and find a dose to use in Part 2 of the trial.Part 2 will study effects of the drugs on a larger group. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1b/2 Study of OMP-59R5 in Combination with Nab-Paclitaxel and Gemcitabine in Subjects with Previously Untreated Stage IV Pancreatic Cancer; ALPINE (59R5-002) The study has two parts: One, test safety and determine the highest tolerable dose of OMP-59R5 when given with nab-paclitaxel and gemcitabine; two, test if OMP-59R5 delays tumor growth or increases life expectancy or shrinks untreated tumors in subjects with stage IV pancreatic cancer. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old